Galderma has established its new US headquarters in Miami, FL, positioning the company at the heart of a thriving market for dermatological skincare, officials said.

Located in the Brickell neighborhood, the company expects to have approximately 150 employees, including US leadership roles, based there by 2028.

Miami’s emergence as a premium market and destination for consumer skincare, consumer health and aesthetic treatments aligns closely with Galderma’s ambitions for its US business, which is the company’s largest region globally and a key driver of future growth.

“Miami’s creativity, energy and forward-thinking spirit are consistent with Galderma’s ambitions,” said Galderma CEO Flemming Ørnskov. “The city’s emergence as a premium destination and a trend-setter in areas closely aligned to our activities, as well as its fast-growing healthcare professional community, makes Miami a natural choice for our US headquarters. Being in Miami will enrich our business with top talent that will prove invaluable to our future success.”

Miami’s Medical Spa Destination

The Miami metro area boasts one of the highest concentrations of medical spas and dermatological aesthetic clinics in the US, with aesthetic procedures growing at an estimated 30% year-over-year. It also hosts the nation’s second-largest medical district, the Miami Health District, with numerous hospitals and research facilities. With over 186,000 healthcare-related jobs and significant growth in startups, Florida is a hub for innovation in health and advanced medical technologies. Miami plays an important role in this ecosystem, with renowned research institutions and medical centers that house dedicated clinical teams focused on dermatology.

“We are delighted to welcome Galderma to the Miami-Dade County area, which has witnessed considerable growth recently as companies increasingly find it to be an attractive location for investment,” said Rodrick Miller, president and CEO, Miami-Dade Beacon Council. “Miami-Dade has established itself as a key player in the life sciences and healthcare industry and having the pure-play dermatology industry leader anchor its U.S. business here will only bolster the region’s reputation for innovation in this sector.”

In addition to its new headquarters in Miami, Galderma will maintain a strong presence across several US locations. Boston will remain the hub for the company’s US Therapeutic Dermatology business and US Research and Development organization. Carlsbad, CA will continue as a hub for Alastin, the company’s premium, physician-dispensed skincare brand. The Dallas, TX, office will continue as one of Galderma’s key U.S. sites while the company’s North America distribution center will remain in Fort Worth, TX.

New Leader of Galderma US

Galderma has appointed Heather Wallace as president of Galderma US. Wallace, past CEO of Curology, will be based in Miami. A proven senior business leader with deep expertise in dermatology and consumer health, she brings a strong track record of delivering commercial success and operational excellence, having served as the leader in personalized prescription skincare, having served as president of the Americas region for Revlon, where she oversaw strategic and cultural transformation efforts to maximize profitability in the company’s largest region.